2021 Q3 Form 10-Q Financial Statement
#000156459021055468 Filed on November 09, 2021
Income Statement
Concept | 2021 Q3 | 2020 Q4 | 2020 Q3 |
---|---|---|---|
Revenue | $3.000M | $6.400M | $7.000K |
YoY Change | 42757.14% | 91328.57% | -12.5% |
Cost Of Revenue | |||
YoY Change | |||
Gross Profit | |||
YoY Change | |||
Gross Profit Margin | |||
Selling, General & Admin | $2.221M | $2.040M | $1.070M |
YoY Change | 107.57% | 2.51% | -39.55% |
% of Gross Profit | |||
Research & Development | $2.382M | $2.530M | $1.768M |
YoY Change | 34.73% | -42.63% | -51.73% |
% of Gross Profit | |||
Depreciation & Amortization | $22.00K | $20.00K | $20.00K |
YoY Change | 10.0% | 0.0% | |
% of Gross Profit | |||
Operating Expenses | $4.603M | $4.570M | $2.839M |
YoY Change | 62.13% | -28.59% | -47.75% |
Operating Profit | -$1.603M | -$2.832M | |
YoY Change | -43.4% | -47.8% | |
Interest Expense | -$6.000K | -$70.00K | -$240.0K |
YoY Change | -97.5% | -74.07% | -38.46% |
% of Operating Profit | |||
Other Income/Expense, Net | -$1.084M | -$160.0K | $810.0K |
YoY Change | -233.83% | -27.27% | -640.0% |
Pretax Income | -$1.365M | $1.610M | -$2.250M |
YoY Change | -39.33% | -123.4% | -62.25% |
Income Tax | $100.0K | $0.00 | $0.00 |
% Of Pretax Income | 0.0% | ||
Net Earnings | -$1.087M | $1.130M | -$1.533M |
YoY Change | -29.09% | -125.69% | -57.51% |
Net Earnings / Revenue | -36.23% | 17.66% | -21900.0% |
Basic Earnings Per Share | |||
Diluted Earnings Per Share | -$17.80K | $22.09K | -$31.72K |
COMMON SHARES | |||
Basic Shares Outstanding | |||
Diluted Shares Outstanding |
Balance Sheet
Concept | 2021 Q3 | 2020 Q4 | 2020 Q3 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $19.57M | $5.700M | $1.800M |
YoY Change | 987.0% | 216.67% | -25.0% |
Cash & Equivalents | $19.60M | $5.747M | $1.827M |
Short-Term Investments | |||
Other Short-Term Assets | $1.677M | $1.300M | $1.800M |
YoY Change | -6.83% | 18.18% | 50.0% |
Inventory | |||
Prepaid Expenses | |||
Receivables | $928.0K | $158.0K | $0.00 |
Other Receivables | $0.00 | $0.00 | $0.00 |
Total Short-Term Assets | $22.17M | $7.215M | $3.700M |
YoY Change | 499.22% | 154.23% | 3.73% |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | $724.0K | $367.0K | $900.0K |
YoY Change | -19.56% | -20.39% | 1856.52% |
Goodwill | |||
YoY Change | |||
Intangibles | |||
YoY Change | |||
Long-Term Investments | $8.539M | $6.700M | $2.500M |
YoY Change | 241.56% | 168.0% | 0.0% |
Other Assets | $0.00 | $0.00 | |
YoY Change | -100.0% | -100.0% | |
Total Long-Term Assets | $9.263M | $7.574M | $3.300M |
YoY Change | 180.7% | 17.83% | -40.59% |
TOTAL ASSETS | |||
Total Short-Term Assets | $22.17M | $7.215M | $3.700M |
Total Long-Term Assets | $9.263M | $7.574M | $3.300M |
Total Assets | $31.43M | $14.79M | $7.000M |
YoY Change | 349.06% | 59.61% | -23.26% |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $4.663M | $1.925M | $5.700M |
YoY Change | -18.19% | -13.75% | -17.39% |
Accrued Expenses | $176.0K | $200.0K | $100.0K |
YoY Change | 76.0% | 100.0% | 0.0% |
Deferred Revenue | $35.00K | $31.00K | |
YoY Change | 0.0% | ||
Short-Term Debt | $0.00 | $84.00K | $334.0K |
YoY Change | -100.0% | -41.67% | -6.7% |
Long-Term Debt Due | $636.0K | $100.0K | $2.400M |
YoY Change | -73.5% | -98.39% | -67.57% |
Total Short-Term Liabilities | $5.510M | $6.390M | $8.300M |
YoY Change | -33.61% | -52.25% | -42.61% |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | -100.0% | ||
Other Long-Term Liabilities | $2.859M | $50.00K | $4.500M |
YoY Change | -36.47% | -80.77% | 1630.77% |
Total Long-Term Liabilities | $2.859M | $50.00K | $4.500M |
YoY Change | -36.47% | -80.77% | 1630.77% |
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $5.510M | $6.390M | $8.300M |
Total Long-Term Liabilities | $2.859M | $50.00K | $4.500M |
Total Liabilities | $52.98M | $11.00M | $58.40M |
YoY Change | -9.28% | -39.27% | 207.32% |
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$259.0M | -$290.0M | |
YoY Change | 24.2% | ||
Common Stock | $209.2M | ||
YoY Change | 13.76% | ||
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | -$21.55M | -$80.10M | -$51.37M |
YoY Change | |||
Total Liabilities & Shareholders Equity | $31.43M | $14.79M | $7.000M |
YoY Change | 349.06% | 59.61% | -23.26% |
Cashflow Statement
Concept | 2021 Q3 | 2020 Q4 | 2020 Q3 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | -$1.087M | $1.130M | -$1.533M |
YoY Change | -29.09% | -125.69% | -57.51% |
Depreciation, Depletion And Amortization | $22.00K | $20.00K | $20.00K |
YoY Change | 10.0% | 0.0% | |
Cash From Operating Activities | -$3.594M | -$2.210M | -$5.440M |
YoY Change | -33.93% | -62.41% | -12.12% |
INVESTING ACTIVITIES | |||
Capital Expenditures | $0.00 | ||
YoY Change | -100.0% | ||
Acquisitions | |||
YoY Change | |||
Other Investing Activities | $0.00 | ||
YoY Change | |||
Cash From Investing Activities | $0.00 | ||
YoY Change | -100.0% | ||
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | |||
YoY Change | |||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | 12.33M | 6.130M | 870.0K |
YoY Change | 1316.67% | 16.1% | -87.32% |
NET CHANGE | |||
Cash From Operating Activities | -3.594M | -2.210M | -5.440M |
Cash From Investing Activities | 0.000 | ||
Cash From Financing Activities | 12.33M | 6.130M | 870.0K |
Net Change In Cash | 8.731M | 3.920M | -4.570M |
YoY Change | -291.05% | -685.07% | -566.33% |
FREE CASH FLOW | |||
Cash From Operating Activities | -$3.594M | -$2.210M | -$5.440M |
Capital Expenditures | $0.00 | ||
Free Cash Flow | -$2.210M | ||
YoY Change | -61.96% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
115000 | ||
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
|
P3Y | ||
CY2020Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
||
us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P5Y8M12D | ||
CY2020Q4 | us-gaap |
Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
|
1009000 | |
CY2020Q4 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
676000 | |
CY2020Q4 | us-gaap |
Due To Related Parties Noncurrent
DueToRelatedPartiesNoncurrent
|
2871000 | |
CY2021Q3 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
2382000 | |
CY2020Q4 | us-gaap |
Notes Payable Current
NotesPayableCurrent
|
84000 | |
CY2020Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
6390000 | |
CY2021Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-1603000 | |
CY2020Q4 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
50000 | |
CY2020Q4 | us-gaap |
Liabilities
Liabilities
|
10996000 | |
CY2020Q4 | us-gaap |
Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
|
83895000 | |
CY2020Q4 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
209161000 | |
CY2020Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-290036000 | |
CY2020Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-80102000 | |
CY2020Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
14789000 | |
CY2020Q3 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
7000 | |
CY2020Q3 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
1768000 | |
CY2021Q3 | us-gaap |
Operating Expenses
OperatingExpenses
|
4603000 | |
CY2020Q3 | us-gaap |
Operating Expenses
OperatingExpenses
|
2839000 | |
CY2020Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-2832000 | |
CY2021Q3 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-1084000 | |
us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
26111000 | ||
us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
9731000 | ||
us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
47000 | ||
us-gaap |
Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
|
-16000 | ||
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-15788000 | ||
vtvt |
Proceeds From Issuance Of Common Stock To Related Party
ProceedsFromIssuanceOfCommonStockToRelatedParty
|
7000000 | ||
us-gaap |
Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
|
-996000 | ||
CY2020Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
5747000 | |
CY2019Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
4277000 | |
CY2020Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-51372000 | |
us-gaap |
Profit Loss
ProfitLoss
|
-8248000 | ||
us-gaap |
Profit Loss
ProfitLoss
|
-14409000 | ||
us-gaap |
Depreciation
Depreciation
|
67000 | ||
vtvt |
Issuance Of Class A Common Stock Under Atm Offering
IssuanceOfClassACommonStockUnderATMOffering
|
9731000 | ||
vtvt |
Stock Issued During Period Value Conversion Of Convertible Securities Related Party
StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesRelatedParty
|
7000000 | ||
us-gaap |
Minority Interest Change In Redemption Value
MinorityInterestChangeInRedemptionValue
|
-10192000 | ||
CY2021Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-47823000 | |
CY2021Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-1087000 | |
CY2021Q3 | vtvt |
Issuance Of Class A Common Stock Under Atm Offering
IssuanceOfClassACommonStockUnderATMOffering
|
11689000 | |
CY2021Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-21545000 | |
CY2020Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-69528000 | |
CY2020Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-1533000 | |
CY2020Q3 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
171000 | |
CY2020Q3 | vtvt |
Issuance Of Class A Common Stock Under Atm Offering
IssuanceOfClassACommonStockUnderATMOffering
|
2451000 | |
CY2020Q3 | us-gaap |
Minority Interest Change In Redemption Value
MinorityInterestChangeInRedemptionValue
|
17067000 | |
CY2020Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-51372000 | |
CY2020Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-80102000 | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-5936000 | ||
vtvt |
Issuance Of Class A Common Stock Under Atm Offering
IssuanceOfClassACommonStockUnderATMOffering
|
17024000 | ||
us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
47000 | ||
vtvt |
Issuance Of Class A Common Stock Under Lpc Agreement
IssuanceOfClassACommonStockUnderLPCAgreement
|
9087000 | ||
us-gaap |
Minority Interest Change In Redemption Value
MinorityInterestChangeInRedemptionValue
|
36973000 | ||
CY2021Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-21545000 | |
CY2019Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-49023000 | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-9625000 | ||
us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
737000 | ||
us-gaap |
Depreciation
Depreciation
|
72000 | ||
us-gaap |
Share Based Compensation
ShareBasedCompensation
|
1362000 | ||
us-gaap |
Share Based Compensation
ShareBasedCompensation
|
737000 | ||
us-gaap |
Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
|
1814000 | ||
vtvt |
Change In Fair Value Of Warrants Related Party
ChangeInFairValueOfWarrantsRelatedParty
|
-611000 | ||
vtvt |
Change In Fair Value Of Warrants Related Party
ChangeInFairValueOfWarrantsRelatedParty
|
114000 | ||
us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
340000 | ||
us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
770000 | ||
us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
9000 | ||
us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
367000 | ||
us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
781000 | ||
vtvt |
Increase Decrease In Long Term Deposits
IncreaseDecreaseInLongTermDeposits
|
-444000 | ||
us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
-1514000 | ||
us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
-1352000 | ||
vtvt |
Accreted Interest On Debt
AccretedInterestOnDebt
|
750000 | ||
us-gaap |
Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
|
-178000 | ||
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-12891000 | ||
us-gaap |
Proceeds From Notes Payable
ProceedsFromNotesPayable
|
887000 | ||
us-gaap |
Proceeds From Notes Payable
ProceedsFromNotesPayable
|
500000 | ||
us-gaap |
Repayments Of Notes Payable
RepaymentsOfNotesPayable
|
335000 | ||
us-gaap |
Repayments Of Notes Payable
RepaymentsOfNotesPayable
|
3893000 | ||
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
26710000 | ||
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
13338000 | ||
us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
13819000 | ||
us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-2450000 | ||
CY2021Q3 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-259000000.0 | |
CY2021Q3 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
19600000 | |
CY2021Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
19566000 | |
CY2020Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
1827000 | |
CY2021Q3 | us-gaap |
Profit Loss
ProfitLoss
|
-1465000 | |
CY2021Q3 | us-gaap |
Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
|
-378000 | |
us-gaap |
Use Of Estimates
UseOfEstimates
|
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires the Company to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On an ongoing basis, the Company evaluates its estimates, including those related to the grant date fair value of equity awards, the fair value of warrants to purchase shares of its Class A Common Stock, the fair value of the Class B Common Stock, the useful lives of property and equipment, the fair value of derivative liabilities, and the fair value of the Company’s debt, among others. The Company bases its estimates on historical experience and on various other assumptions that it believes to be reasonable, the results of which form the basis for making judgments about the carrying value of assets and liabilities.</p> | ||
us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Concentration of Credit Risk</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial instruments that potentially expose the Company to concentrations of credit risk consist principally of cash on deposit with multiple financial institutions. The balances of these cash accounts frequently exceed insured limits.</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Two and three customers represented 100% of the revenue earned during the three months and nine months ended September 30, 2021, respectively. Revenue for the three and nine months ended September 30, 2020 was insignificant.</p> | ||
us-gaap |
Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
|
0 | ||
CY2021Q3 | vtvt |
Adjustments To Transaction Price For Performance Obligations
AdjustmentsToTransactionPriceForPerformanceObligations
|
0 | |
vtvt |
Adjustments To Transaction Price For Performance Obligations
AdjustmentsToTransactionPriceForPerformanceObligations
|
0 | ||
CY2021Q3 | us-gaap |
Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
|
0 | |
CY2021Q3 | us-gaap |
Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
|
35000 | |
CY2020Q4 | us-gaap |
Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
|
31000 | |
CY2021Q3 | us-gaap |
Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
|
9000 | |
CY2020Q4 | us-gaap |
Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
|
1009000 | |
CY2021Q3 | us-gaap |
Contract With Customer Liability
ContractWithCustomerLiability
|
44000 | |
CY2020Q4 | us-gaap |
Contract With Customer Liability
ContractWithCustomerLiability
|
1040000 | |
us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
|
P10Y | ||
CY2021Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
|
4296594 | |
CY2021Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
|
4.42 | |
us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
|
P7Y3M18D | ||
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
|
1.2037 | ||
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
|
0.0039 | ||
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0.0000 | ||
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
|
0.0000 | ||
CY2020Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
4453357 | |
CY2020Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
4.41 | |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
70000 | ||
us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
2.56 | ||
us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
20833 | ||
us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
2.24 | ||
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
|
28121 | ||
us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
|
15.00 | ||
CY2021Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
4474403 | |
CY2021Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
4.32 | |
CY2021Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
2164063 | |
CY2021Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
|
6.68 | |
us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
|
P5Y7M6D | ||
CY2021Q3 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
474000 | |
CY2021Q3 | us-gaap |
Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
|
8539000 | |
CY2020Q4 | us-gaap |
Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
|
6725000 | |
CY2021Q3 | us-gaap |
Debt Instrument Interest Rate Effective Percentage
DebtInstrumentInterestRateEffectivePercentage
|
0.215 | |
CY2021Q3 | us-gaap |
Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
|
0.131 | |
CY2020Q4 | us-gaap |
Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
|
0.131 | |
CY2021Q3 | us-gaap |
Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
|
P3Y3M18D | |
CY2020Q4 | us-gaap |
Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
|
P4Y1M6D | |
CY2021Q3 | us-gaap |
Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
|
64000 | |
CY2021Q3 | us-gaap |
Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
|
261000 | |
CY2021Q3 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
|
268000 | |
CY2021Q3 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
|
275000 | |
CY2021Q3 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
|
23000 | |
CY2021Q3 | us-gaap |
Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
|
891000 | |
CY2021Q3 | vtvt |
Operating Leases Imputed Interest
OperatingLeasesImputedInterest
|
175000 | |
CY2021Q3 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
716000 | |
CY2021Q3 | vtvt |
Redeemable Noncontrolling Interest Temporary Equity Redemption Value
RedeemableNoncontrollingInterestTemporaryEquityRedemptionValue
|
44600000 | |
CY2020Q4 | vtvt |
Redeemable Noncontrolling Interest Temporary Equity Redemption Value
RedeemableNoncontrollingInterestTemporaryEquityRedemptionValue
|
83900000 | |
CY2020Q4 | vtvt |
Common Stock And Preferred Stock Shares Authorized
CommonStockAndPreferredStockSharesAuthorized
|
250000000 | |
CY2021Q2 | vtvt |
Common Stock And Preferred Stock Shares Authorized
CommonStockAndPreferredStockSharesAuthorized
|
350000000 | |
CY2021Q3 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-1087000 | |
CY2020Q3 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-1533000 | |
us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-5936000 | ||
us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-9625000 | ||
CY2021Q3 | us-gaap |
Consolidation Less Than Wholly Owned Subsidiary Parent Ownership Interest Changes Purchase Of Interest By Parent
ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesPurchaseOfInterestByParent
|
2773000 | |
CY2021Q3 | us-gaap |
Consolidation Less Than Wholly Owned Subsidiary Parent Ownership Interest Change Due To Net Income Attributable To Parent And Effects Of Changes Net
ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangeDueToNetIncomeAttributableToParentAndEffectsOfChangesNet
|
-3860000 | |
CY2021Q3 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
100000 | |
CY2020Q3 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | |
us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | ||
us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.21 | ||
CY2020Q3 | us-gaap |
Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
|
-720000 | |
us-gaap |
Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
|
-2312000 | ||
us-gaap |
Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
|
-4784000 | ||
vtvt |
Net Income Loss Available To Common Stockholders Basic And Diluted
NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted
|
-5936000 | ||
vtvt |
Net Income Loss Available To Common Stockholders Basic And Diluted
NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted
|
-9625000 | ||
us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
29582766 | ||
us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
29583915 |